Literature DB >> 27852481

Mitral Paravalvular Leak Closure.

Paul Sorajja1.   

Abstract

For patients with paravalvular mitral prosthetic regurgitation, percutaneous repair is an established therapy for the treatment of symptoms of heart failure or hemolytic anemia. Percutaneous repair of paravalvular mitral regurgitation is a complex procedure with unique technical challenges, even when performed in experienced centers. Herein, the author discusses patient selection, catheter-based techniques for repair, and clinical outcomes of percutaneous repair for paravalvular mitral regurgitation.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Leak closure; Mitral; Paravalvular; Regurgitation

Mesh：

Year:  2015        PMID： 27852481     DOI： 10.1016/j.iccl.2015.08.004

Source DB:  PubMed          Journal:  Interv Cardiol Clin        ISSN： 2211-7458


  5 in total

Review 1.  Mitral Valve Interventions in Structural Heart Disease.

Authors:  Matteo Saccocci; Maurizio Taramasso; Francesco Maisano
Journal:  Curr Cardiol Rep       Date:  2018-05-17       Impact factor: 2.931

2.  Closure of a Prosthetic Mitral Valve Paravalvular Leak Using a Ventricular Septal Defect (VSD) Amplatzer Occluder Device.

Authors:  Oreoluwa Oladiran; Gabriel Areoye; Adeolu O Oladunjoye; Olubunmi O Oladunjoye; Eric Elgin; Anthony Licata
Journal:  Am J Case Rep       Date:  2021-01-30

3.  Transcatheter Closure of Mitral Paravalvular Leak via Multiple Approaches.

Authors:  Yang Liu; Chennian Xu; Peng Ding; Jiayou Tang; Ping Jin; Lanlan Li; Min Chen; Xin Meng; Hongliang Zhao; Jian Yang
Journal:  J Interv Cardiol       Date:  2021-03-02       Impact factor: 2.279

Review 4.  Mitral Paravalvular Leak: Clinical Implications, Diagnosis and Management.

Authors:  Ignacio Cruz-Gonzalez; Pablo Antunez-Muiños; Sergio Lopez-Tejero; Pedro L Sanchez
Journal:  J Clin Med       Date:  2022-02-25       Impact factor: 4.241

5.  Percutaneous Closure of Mitral Paravalvular Leak: Long-Term Results in a Single-Center Experience.

Authors:  Ignacio Cruz-González; Pablo Luengo-Mondéjar; Blanca Trejo-Velasco; Jean C Núñez-García; Rocío González-Ferreiro; José C Moreno-Samos; Mónica Fuertes-Barahona; Juan C Rama-Merchán; Pablo Antúnez-Muiños; Sergio López-Tejero; Gilles Barreira de Sousa; Javier Rodríguez-Collado; Javier Martín-Moreiras; Alejandro Diego-Nieto; Jesús Herrero-Garibi; Manuel Barreiro-Pérez; Elena Díaz-Peláez; Pedro L Sánchez Fernández
Journal:  J Clin Med       Date:  2022-08-18       Impact factor: 4.964
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.